Fonte: Pediatric Blood and Cancer. Nome do evento: Congress Meeting of the International Society of Pediatric Oncology-SIOP. Unidade: FMRP
Assuntos: ONCOLOGIA, PEDIATRIA
ABNT
MURAD, J. M. et al. A point mutation of the tumor supressor gene PKR in childhood leukemia abolishes activation of protein kinase by a synthetic RNA. 2004, Anais.. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2004. p. 390. . Acesso em: 31 out. 2024.APA
Murad, J. M., Souza, L. R., Tone, L. G., & De Lucca, E. L. (2004). A point mutation of the tumor supressor gene PKR in childhood leukemia abolishes activation of protein kinase by a synthetic RNA. In Pediatric Blood and Cancer (Vol. 43, p. 390). Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Murad JM, Souza LR, Tone LG, De Lucca EL. A point mutation of the tumor supressor gene PKR in childhood leukemia abolishes activation of protein kinase by a synthetic RNA. Pediatric Blood and Cancer. 2004 ; 43( 4): 390.[citado 2024 out. 31 ]Vancouver
Murad JM, Souza LR, Tone LG, De Lucca EL. A point mutation of the tumor supressor gene PKR in childhood leukemia abolishes activation of protein kinase by a synthetic RNA. Pediatric Blood and Cancer. 2004 ; 43( 4): 390.[citado 2024 out. 31 ]